Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer

  • Technology appraisal guidance
  • TA1158
  • Published: 

Tools and resources

Tools and resources to help you put the guidance into practice.

Education

Resource impact

Guidance into practice